Financials Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 11:57:43 2026-01-21 am EST			5-day change	1st Jan Change
5.745 ^USD	+1.14%		-5.48%	-6.10%

Jan. 14	Myriad Genetics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 05:15 PM
Jan. 12	Myriad Genetics, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 and 2026	CI

Projected Income Statement: Myriad Genetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	557	690.6	678.4	753.2	837.6	822.6	868.1	917.1
Change	-	23.99%	-1.77%	11.03%	11.21%	-1.79%	5.54%	5.65%
EBITDA ¹	-	71.9	-21	-6.3	40.4	30.74	36.95	47.13
Change	-	-	-129.21%	70%	741.27%	-23.92%	20.2%	27.57%
EBIT ¹	-77.9	9.1	-32.8	-25.5	21.8	7.048	13.22	20.32
Change	-	111.68%	-460.44%	22.26%	185.49%	-67.67%	87.58%	53.72%
Interest Paid ¹	-7.8	-5.9	-3.2	-2.9	-2.8	-9.275	-13.85	-13.87
Earnings before Tax (EBT) ¹	-	-57.1	-140.6	-262.2	-123.5	-406.7	-63.43	-45.87
Change	-	-	-146.23%	-86.49%	52.9%	-229.29%	84.4%	27.69%
Net income ¹	-	-27.2	-112	-263.3	-127.3	-378.5	-64.13	-47.47
Change	-	-	-311.76%	-135.09%	51.65%	-197.31%	83.06%	25.98%
Announcement Date	2/23/21	2/24/22	2/28/23	2/27/24	2/24/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	154.6	173.1	189.4	167.3	160.8	164.9	179.3	156.4	177.8	181.2	183.5	191.9	196.6	202.2	211.5	213.3	210.6	195.9	213.1	205.7	207	211.7	220.2	216.8	218.7	225.6	231.1	229.1
Change	-	11.97%	9.42%	-11.67%	-3.89%	2.55%	8.73%	-12.77%	13.68%	1.91%	1.27%	4.58%	2.45%	2.85%	4.6%	0.85%	-1.27%	-6.98%	8.78%	-3.47%	0.61%	2.31%	4.01%	-1.57%	0.91%	3.15%	2.42%	-0.87%
EBITDA ¹	-	15.1	30.4	12.8	13.4	10.2	7.3	-17.6	-10.7	-20.5	-4.2	1.2	10.1	4.4	11.9	14.1	10.6	-0.1	14.5	10.3	6.455	8.596	10.17	9.536	8.64	14.29	11.19	10.23
Change	-	-	101.32%	-57.89%	4.69%	-23.88%	-28.43%	-341.1%	39.2%	-91.59%	79.51%	128.57%	741.67%	-56.44%	170.45%	18.49%	-24.82%	-100.94%	14,600%	-28.97%	-37.33%	33.17%	18.34%	-6.26%	-9.4%	65.39%	-21.7%	-8.57%
EBIT ¹	-11.3	-3.3	13.5	-1.4	0.1	-2.8	4.5	-20.6	-13.9	-21.9	-6.8	-2.2	5.7	-0.6	7.4	9.5	5.6	-5.5	8.6	4.1	-0.1648	2.381	4.607	3.611	1.16	5.305	6.932	6.321
Change	-	70.8%	509.09%	-110.37%	107.14%	-2,900%	260.71%	-557.78%	32.52%	-57.55%	68.95%	67.65%	359.09%	-110.53%	1,333.33%	28.38%	-41.05%	-198.21%	256.36%	-52.33%	-104.02%	1,545.21%	93.44%	-21.61%	-67.89%	357.43%	30.67%	-8.8%
Charge d'intérêts ¹	-2.6	-2.8	-1.8	-0.9	-0.4	-0.9	-0.6	-0.8	-0.9	-0.5	-0.5	-1	-0.9	-0.5	-0.8	-0.8	-0.7	-0.8	-1.5	-3.8	-3.425	-3.45	-3.45	-3.425	-3.425	-3.6	-3.6	-3.6
Earnings before Tax (EBT) ¹	-	-49.6	-3.8	39.8	-43.5	-26.4	-17.9	-44.2	-52.1	-52.6	-116.1	-61.2	-32.3	-25.9	-37.2	-21.2	-39.1	-29.4	-330.6	-26.2	-20.47	-18.31	-14.84	-14.85	-15.43	-14.63	-13.63	-11.9
Change	-	-	92.34%	1,147.37%	-209.3%	39.31%	32.2%	-146.93%	-17.87%	-0.96%	-120.72%	47.29%	47.22%	19.81%	-43.63%	43.01%	-84.43%	24.81%	-1,024.49%	92.08%	21.85%	10.55%	19%	-0.09%	-3.92%	5.17%	6.84%	12.74%
Net income ¹	-	-39.5	-4.7	24.6	-7.6	-20.5	-14.1	-35.1	-42.3	-54.7	-116.1	-61.3	-31.2	-26	-36.7	-22.1	-42.5	-0.1	-330.5	-27.4	-20.47	-18.71	-14.7	-15.11	-15.6	-15.48	-13.73	-12.7
Change	-	-	88.1%	623.4%	-130.89%	-169.74%	31.22%	-148.94%	-20.51%	-29.31%	-112.25%	47.2%	49.1%	16.67%	-41.15%	39.78%	-92.31%	99.76%	-330,400%	91.71%	25.27%	8.6%	21.44%	-2.81%	-3.19%	0.73%	11.31%	7.55%
Announcement Date	2/23/21	5/3/21	8/3/21	11/2/21	2/24/22	5/5/22	8/4/22	11/1/22	2/28/23	5/3/23	8/3/23	11/6/23	2/27/24	5/7/24	8/6/24	11/7/24	2/24/25	5/6/25	8/5/25	11/3/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Myriad Genetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	108	-340	-115	-102	-62.8	-20.3	-21.8	-25.9
Change	-	-414.81%	66.18%	11.3%	38.43%	67.68%	-7.39%	-18.81%
Announcement Date	2/23/21	2/24/22	2/28/23	2/27/24	2/24/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Myriad Genetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	10.2	18	45.3	63.2	19	18.85	23.67	25.19
Change	-	76.47%	151.67%	39.51%	-69.94%	-0.78%	25.57%	6.41%
Free Cash Flow (FCF) ¹	-64.6	162.2	-151.6	-174.1	-27.7	-30.8	-4.3	11.3
Change	-	351.08%	-193.46%	-14.84%	84.09%	-11.19%	86.04%	362.79%
Announcement Date	2/23/21	2/24/22	2/28/23	2/27/24	2/24/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Myriad Genetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	10.41%	-3.1%	-0.84%	4.82%	3.74%	4.26%	5.14%
EBIT Margin (%)	-13.99%	1.32%	-4.83%	-3.39%	2.6%	0.86%	1.52%	2.22%
EBT Margin (%)	-	-8.27%	-20.73%	-34.81%	-14.74%	-49.44%	-7.31%	-5%
Net margin (%)	-	-3.94%	-16.51%	-34.96%	-15.2%	-46.01%	-7.39%	-5.18%
FCF margin (%)	-11.6%	23.49%	-22.35%	-23.11%	-3.31%	-3.74%	-0.5%	1.23%
FCF / Net Income (%)	-	-596.32%	135.36%	66.12%	21.76%	8.14%	6.71%	-23.81%
Profitability
ROA	-3.57%	0.1%	-1.92%	-1.93%	1.15%	-	-	-
ROE	-5.6%	0.15%	-12.08%	-2.71%	1.68%	0.01%	-0.64%	1.38%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-1.67x	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	1.83%	2.61%	6.68%	8.39%	2.27%	2.29%	2.73%	2.75%
CAPEX / EBITDA (%)	-	25.03%	-215.71%	-1,003.17%	47.03%	61.34%	64.08%	53.45%
CAPEX / FCF (%)	-15.79%	11.1%	-29.88%	-36.3%	-68.59%	-61.21%	-550.56%	222.94%
Items per share
Cash flow per share ¹	-	0.2333	-1.319	-1.339	-0.096	1.402	1.657	-
Change	-	-	-665.23%	-1.53%	92.83%	1,560.74%	18.15%	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	11.68	12.1	10.91	8.712	7.679	3.94	3.803	3.785
Change	-	3.54%	-9.83%	-20.14%	-11.86%	-48.69%	-3.5%	-0.46%
EPS ¹	-3.08	-0.35	-1.39	-3.18	-1.41	-4.087	-0.6767	-0.4933
Change	-	88.64%	-297.14%	-128.78%	55.66%	-189.83%	83.44%	27.09%
Nbr of stocks (in thousands)	75,210	79,855	81,034	88,669	91,035	93,214	93,214	93,214
Announcement Date	2/23/21	2/24/22	2/28/23	2/27/24	2/24/25	-	-	-